News & Press Releases Swedish

Scandinavian ChemoTech i final till Swecare Rising Star Awards 2021

Priset, som delas ut av socialminister Lena Hallengren den 29 april, tilldelas två svenska hälso- och sjukvårdsföretag som åstadkommit utmärkande internationella exportsatsningar.

Read more

Scandinavian ChemoTech välkomnar ny kraft till ledningsgruppen

Scandinavian ChemoTech meddelar att Ulf Lundgren, ansvarig för QA/RA, har valt att varva ner och avsluta sitt uppdrag och kommer att ersättas av Eva Ståhl Wernersson.

Read more

Scandinavian ChemoTech AB förbereder för expansion och rekryterar en Chief Operating Officer

ChemoTech signerade idag avtal med Urban Widén som på konsultbasis kommer att gå in som bolagets Chief Operating Officer. En strategisk roll där han tillsammans med VDn och grundaren Mohan Frick kommer att ta bolaget in i en ny och spännande fas.

Read more

News & Press Releases English

Scandinavian ChemoTech AB (publ) strengthening its position despite ongoing pandemic - Q4 report 2020

Year-End Report January – December 2020 EXECUTIVE SUMMARY Fourth quarter · Net sales amounted to kSEK 0 (72) · Profit before tax amounted to kSEK -2 792 (-4 663) · Earnings per share amounted to SEK -0,46 SEK (-1,37) · Cash flow from operating activities totalled to kSEK -2 794 (-3 159) · The Order…

Read more

Scandinavian ChemoTech receives a final injunction from the European Patent Office

Scandinavian ChemoTech AB announces today that the Company has received a final injunction from the European Patent Office where the examiner announces that the patent for the Company's innovation, for TSE treatment of skeletal metastases and deep-seated tumours, will be granted.

Read more

Scandinavian ChemoTech enters into an agreement with Erik Penser Bank to monitor the company in the form of assignment analyses

Scandinavian ChemoTech AB (publ) has entered into an agreement with Erik Penser Bank AB to receive the service, Penser Access, where written analysis reports are the central part of the service.

Read more

Chemotech Videos

CEO Mohan Frick presenting at Erik Penser Bank Bolagsdag (Swedish)

Erik Penser Bank interview with CEO Mohan Frick (Swedish)

Company Presentation of the Q3 report (Swedish) 11th of November 2020

Company Presentation (Swedish) 27th of October 2020

Share Day in Gothenburg, November 4 2019

Share Day in Malmö on May 22, 2018

Share analysis ChemoTech Q2 2018

Our foundation

Our profound knowledge in Electroporation forms the starting point for the company’s existing product and R&D projects : IQwave™ specially desinged for both Dynamic-ElectroEnhanced Chemotherapy and the first generation Electrochemotherpy for the treatment of a range of different types of tumors.

Our research focus

Our aim is to document the effects of elctrochemotherapy for pain management for cancer patients, an area with significant unmet medical need.